Physician profile
Grace Dorsch
NPI 1740257815
$1,516.00
in general payments reported to CMS, 2019-2025
17 companies · $357 in 2025
The $357 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.65 · 2020: $88.42 · 2021: $218 · 2022: $64.83 · 2023: $190 · 2024: $580 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $707.07 | 2020-2025 | Skyrizi, Rinvoq, Humira |
| Takeda Pharmaceuticals U.S.A., INC. | $198.87 | 2023-2025 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.92 | 2020-2025 | Xifaxan, Trulance |
| Fresenius Kabi USA, LLC | $64.83 | 2022 | |
| Ardelyx, INC. | $64.17 | 2025 | Ibsrela |
| Zimvie INC. | $60.33 | 2024 | |
| Lilly USA, LLC | $45.94 | 2024-2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $45.74 | 2025 | Dupixent |
| Eagle Pharmaceuticals, INC. | $39.85 | 2023 | |
| Phathom Pharmaceuticals, INC. | $35.59 | 2024 | Voquezna |
| Eisai INC. | $24.16 | 2020 | |
| Biohorizons Implant Systems INC. | $18.03 | 2023 | Biohorizons |
| Braintree Laboratories, INC. | $17.65 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.14 | 2021 | |
| Zimmer Biomet Holdings, INC. | $15.93 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.27 | 2024 | Stelara |
| Intercept Pharmaceuticals, INC. | $13.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Dorsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.